VivoSim Labs, Inc. (VIVS) Total liabilities 2017–2026
VivoSim Labs, Inc. (VIVS) total liabilities at each fiscal year-end, per SEC filings.
$8.5MFY2026 · since FY2017: $6.8M → $8.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $8.5M | +104.1% |
| FY2025 | $4.2M | +51.3% |
| FY2024 | $2.7M | -44.9% |
| FY2023 | $5.0M | +61.5% |
| FY2022 | $3.1M | +328.2% |
| FY2021 | $721,000 | -60.2% |
| FY2020 | $1.8M | -58.2% |
| FY2019 | $4.3M | -17.5% |
| FY2018 | $5.2M | -23.1% |
| FY2017 | $6.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More VIVS financial trends
VIVS RevenueVIVS Net incomeVIVS Net marginVIVS Gross profitVIVS Gross marginVIVS Operating incomeVIVS Operating marginVIVS Operating cash flowVIVS Free cash flowVIVS Capital expendituresVIVS Return on equityVIVS Stock buybacksVIVS Dividends paidVIVS Total assetsVIVS Shareholders’ equityVIVS overview →